GSK chief executive Andrew Witty told investors yesterday that Advair/Seretide sales are likely to continue to decline, although he insisted that the company is starting to see "some recovery in ...
Here is a hard truth for those of us who are care providers: Americans are unsatisfied with the country's healthcare system.
The big picture: UnitedHealth Group CEO Andrew Witty spoke at length Thursday about ... The intrigue: Witty is a former CEO of British drug company GSK. During his tenure there, he told CNBC ...
executive Andrew Witty Thursday said the U.S. healthcare ... who ran the big drugmaker GlaxoSmithKline for nearly a decade before joining UnitedHealth Group’s management team to run Optum ...
UnitedHealth UNH.N CEO Andrew Witty said on Thursday that healthcare ... who was previously CEO of British drugmaker GlaxoSmithKline GSK.L. Drug costs:FTC report shows $7.3 billion in drug ...
(Reuters) -UnitedHealth CEO Andrew Witty said on Thursday that healthcare ... who was previously CEO of British drugmaker GlaxoSmithKline. UnitedHealth, which operates the biggest health insurer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results